APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
- 1 March 1996
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 25 (1) , 1-25
- https://doi.org/10.1016/s0889-8529(05)70310-8
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Clinical use of molecular information in the management of multiple endocrine neoplasia type 2AJournal of Internal Medicine, 1995
- Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's diseaseSurgery, 1995
- Identification of a polymorphism in exon 11 of the RET proto-oncogeneHuman Molecular Genetics, 1994
- RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancerHuman Molecular Genetics, 1994
- One gene—four syndromesNature, 1994
- The Role of Genetic Screening in the Management of Hereditary MalignancyHormone and Metabolic Research, 1993
- HEREDITARY LOCALIZED PRURITUS IN AFFECTED MEMBERS OF A KINDRED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (SIPPLE'S SYNDROME)Clinical Endocrinology, 1989
- The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1988
- Cancer Risks in Patients with Chronic Lymphocytic ThyroiditisNew England Journal of Medicine, 1985
- Natural History of Familial Medullary Thyroid CarcinomaNew England Journal of Medicine, 1978